Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA
Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA
www.bloomberg.com Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA
GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
